Position in RPRX
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$35,799,386
+$6,962,858 QoQ
Shares Held
746,287
0.0% QoQ
Ownership
0.130%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DekaBank Deutsche Girozentrale holds $665,183,872 across 48 Biotechnology names. RPRX ranks #5 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
506,457 | $226,153,308 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
211,207 | $163,186,975 | |
| 3 | BNTX |
BioNTech SE
|
481,397 | $42,786,564 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
113,193 | $37,452,167 | |
| 5 | RPRX |
Royalty Pharma plc
This page
|
746,287 | $35,799,386 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
115,130 | $21,765,325 | |
| 7 | EXEL |
Exelixis, Inc.
|
429,690 | $18,429,403 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
280,330 | $15,835,841 |
All Filings in RPRX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $35,799,386 | 746,287 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $28,836,528 | 746,287 | Shares | Defined | 2026-01-28 | |
| 2025-09-30 | $26,329,004 | 746,287 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $26,888,720 | 746,287 | Shares | Defined | 2025-07-30 | |
| 2025-03-31 | $23,327,078 | 749,344 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $19,037,781 | 746,287 | Shares | Defined | 2025-01-29 | |
| 2024-09-30 | $21,112,458 | 746,287 | Shares | Defined | 2024-10-24 | |
| 2024-06-30 | $19,227,104 | 729,128 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $22,757,576 | 749,344 | Shares | Defined | 2024-06-04 | |
| 2023-12-31 | $13,280,895 | 472,798 | Shares | Defined | 2024-01-24 | |
| 2023-09-30 | $13,016,994 | 479,624 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $14,570,174 | 473,981 | Shares | Defined | 2023-07-25 | |
| 2023-03-31 | $16,525,050 | 458,647 | Shares | Defined | 2023-04-24 | |
| 2022-12-31 | $19,686,018 | 498,128 | Shares | Defined | 2023-02-01 | |
| 2022-09-30 | $11,302,674 | 281,301 | Shares | Defined | 2022-11-02 | |
| 2022-06-30 | $8,902,600 | 211,765 | Shares | Defined | 2022-08-03 | |
| 2022-03-31 | $8,312,193 | 213,352 | Shares | Defined | 2022-04-28 | |
| 2021-12-31 | $4,759,923 | 119,446 | Shares | Defined | 2022-02-02 | |
| 2021-09-30 | $3,969,147 | 109,827 | Shares | Defined | 2021-10-22 | |
| 2021-06-30 | $4,541,364 | 110,792 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $4,715,060 | 108,094 | Shares | Defined | 2021-04-28 | |
| 2020-12-31 | $4,175,571 | 83,428 | Shares | Defined | 2021-03-12 | |
| 2020-06-30 | $1,019,550 | 21,000 | Shares | Defined | 2020-08-04 | |
| No filing history on record for this holder in this stock. | ||||||